- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 390789, 9 pages
Identification, Selection, and Enrichment of Cardiomyocyte Precursors
1Department of Biophysics, Gene Therapy Investigation Center, Universidade Federal de São Paulo, Rua Mirassol 207, 04044-010 São Paulo, SP, Brazil
2Department of Surgery, Universidade Federal de São Paulo, São Paulo, SP, Brazil
Received 14 February 2013; Revised 12 May 2013; Accepted 25 May 2013
Academic Editor: Sanford I. Bernstein
Copyright © 2013 Bianca Ferrarini Zanetti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- V. L. Roger, A. S. Go, D. M. Lloyd-Jones, et al., “Heart disease and stroke statistics—2012 update: a report from the American Heart Association,” Circulation, vol. 125, article e2-e220, 2012.
- M. Jessup and S. Brozena, “Medical progress: heart failure,” The New England Journal of Medicine, vol. 348, no. 20, pp. 2007–2018, 2003.
- E. G. Nabel and E. Braunwald, “A tale of coronary artery disease and myocardial infarction,” The New England Journal of Medicine, vol. 366, no. 1, pp. 54–63, 2012.
- H. Zimmet and H. Krum, “Using adult stem cells to treat heart failure-fact or fiction?” Heart Lung and Circulation, vol. 17, supplement 4, pp. S48–S54, 2008.
- A. P. Beltrami, L. Barlucchi, D. Torella et al., “Adult cardiac stem cells are multipotent and support myocardial regeneration,” Cell, vol. 114, no. 6, pp. 763–776, 2003.
- I. Kehat, D. Kenyagin-Karsenti, M. Snir et al., “Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes,” Journal of Clinical Investigation, vol. 108, no. 3, pp. 407–414, 2001.
- G. Vogel, “Ready or not? Human ES cells head toward the clinic,” Science, vol. 308, no. 5728, pp. 1534–1538, 2005.
- K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006.
- P. Bianco, P. G. Robey, and P. J. Simmons, “Mesenchymal stem cells: revisiting history, concepts, and assays,” Cell Stem Cell, vol. 2, no. 4, pp. 313–319, 2008.
- A. R. Williams and J. M. Hare, “Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease,” Circulation Research, vol. 109, no. 8, pp. 923–940, 2011.
- Y. S. Choi, G. J. Dusting, S. Stubbs et al., “Differentiation of human adipose-derived stem cells into beating cardiomyocytes,” Journal of Cellular and Molecular Medicine, vol. 14, no. 4, pp. 878–889, 2010.
- K. Fukuda, “Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering,” Artificial Organs, vol. 25, no. 3, pp. 187–193, 2001.
- K. G. Gaustad, A. C. Boquest, B. E. Anderson, A. M. Gerdes, and P. Collas, “Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes,” Biochemical and Biophysical Research Communications, vol. 314, no. 2, pp. 420–427, 2004.
- S. Makino, K. Fukuda, S. Miyoshi et al., “Cardiomyocytes can be generated from marrow stromal cells in vitro,” Journal of Clinical Investigation, vol. 103, no. 5, pp. 697–705, 1999.
- S. Rangappa, C. Fen, E. H. Lee, et al., “Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes,” Annals of Thoracic Surgery, vol. 75, no. 3, pp. 775–779, 2003.
- S. H. Choi, S. Y. Jung, S. M. Kwon, et al., “Perspectives on stem cell therapy for cardiac regeneration,” Circulation Journal, vol. 76, no. 6, pp. 1307–1312, 2012.
- D. Bernhard and G. Laufer, “The aging cardiomyocyte: a mini-review,” Gerontology, vol. 54, no. 1, pp. 24–31, 2008.
- C. de Diego, F. Chen, L.-H. Xie et al., “Cardiac alternans in embryonic mouse ventricles,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 294, no. 1, pp. H433–H440, 2008.
- M. Nishi, N. M. Kumar, and N. B. Gilula, “Developmental regulation of gap junction gene expression during mouse embryonic development,” Developmental Biology, vol. 146, no. 1, pp. 117–130, 1991.
- R. Zeller, K. D. Bloch, B. S. Williams, R. J. Arceci, and C. E. Seidman, “Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis,” Genes & Development, vol. 1, no. 7, pp. 693–698, 1987.
- M. Wankerl, K. R. Boheler, M. Y. Fiszman, and K. Schwartz, “Molecular cloning and analysis of the human cardiac sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) gene promoter,” Journal of Molecular and Cellular Cardiology, vol. 28, no. 10, pp. 2139–2150, 1996.
- D. A. Rubinson, C. P. Dillon, A. V. Kwiatkowski, et al., “A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference,” Nature Genetics, vol. 33, no. 3, pp. 401–406, 2003.
- J. R. de Leon, P. M. Buttrick, and G. I. Fishman, “Functional analysis of the connexin43 gene promoter in vivo and in vitro,” Journal of Molecular and Cellular Cardiology, vol. 26, no. 3, pp. 379–389, 1994.
- C. O. Echetebu, M. Ali, M. G. Izban, L. MacKay, and R. E. Garfield, “Localization of regulatory protein binding sites in the proximal region of human myometrial connexin 43 gene,” Molecular Human Reproduction, vol. 5, no. 8, pp. 757–766, 1999.
- L. J. Field, “Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice,” Science, vol. 239, no. 4843, pp. 1029–1033, 1988.
- E. Geimonen, W. Jiang, M. Ali, G. I. Fishman, R. E. Garfield, and J. Andersen, “Activation of protein kinase C in human uterine smooth muscle induces connexin-43 gene transcription through an AP-1 site in the promoter sequence,” Journal of Biological Chemistry, vol. 271, no. 39, pp. 23667–23674, 1996.
- R. B. DuBridge, P. Tang, and H. C. Hsia, “Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system,” Molecular and Cellular Biology, vol. 7, no. 1, pp. 379–387, 1987.
- G. J. Todaro and H. Green, “Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines,” Journal of Cell Biology, vol. 17, pp. 299–313, 1963.
- B. W. Kimes and B. L. Brandt, “Properties of a clonal muscle cell line from rat heart,” Experimental Cell Research, vol. 98, no. 2, pp. 367–381, 1976.
- K. Takahashi, Y. Sawasaki, J.-I. Hata, K. Mukai, and T. Goto, “Spontaneous transformation and immortalization of human endothelial cells,” In Vitro Cellular and Developmental Biology, vol. 26, no. 3, pp. 265–274, 1990.
- P. A. Zuk, M. Zhu, P. Ashjian et al., “Human adipose tissue is a source of multipotent stem cells,” Molecular Biology of the Cell, vol. 13, no. 12, pp. 4279–4295, 2002.
- I. Barde, P. Salmon, and D. Trono, “Production and titration of lentiviral vectors,” Current Protocols in Neuroscience, no. 53, pp. 4.21.1–4.21.23, 2010.
- K. Okita, M. Nakagawa, H. Hyenjong, T. Ichisaka, and S. Yamanaka, “Generation of mouse induced pluripotent stem cells without viral vectors,” Science, vol. 322, no. 5903, pp. 949–953, 2008.
- M. Boshart, F. Weber, and G. Jahn, “A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus,” Cell, vol. 41, no. 2, pp. 521–530, 1985.
- P. Thomas and T. G. Smart, “HEK293 cell line: a vehicle for the expression of recombinant proteins,” Journal of Pharmacological and Toxicological Methods, vol. 51, no. 3, pp. 187–200, 2005.
- M. Geraerts, S. Willems, V. Baekelandt, Z. Debyser, and R. Gijsbers, “Comparison of lentiviral vector titration methods,” BMC Biotechnology, vol. 6, article 34, 2006.
- J. Y. Qin, L. Zhang, K. L. Clift et al., “Systematic comparison of constitutive promoters and the doxycycline-inducible promoter,” Plos One, vol. 5, no. 5, article e10611, 2010.
- P. Mastromarino, C. Conti, P. Goldoni, B. Hauttecoeur, and N. Orsi, “Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH,” Journal of General Virology, vol. 68, part 9, 1987.
- F. B. Engel, M. Schebesta, M. T. Duong et al., “p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes,” Genes and Development, vol. 19, no. 10, pp. 1175–1187, 2005.
- D. H. Kim, K. H. Yoo, K. S. Choi, et al., “Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell,” Cytokine, vol. 31, no. 2, pp. 119–126, 2005.
- A. K. Sharma, N. J. Fuller, R. R. Sullivan et al., “Defined populations of bone marrow derived mesenchymal stem and endothelial progenitor cells for bladder regeneration,” Journal of Urology, vol. 182, no. 4, pp. 1898–1905, 2009.
- J. Van Tuyn, D. A. Pijnappels, A. A. F. de Vries et al., “Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene,” FASEB Journal, vol. 21, no. 12, pp. 3369–3379, 2007.
- F.-B. Zhang, L. Li, B. Fang, D.-L. Zhu, H.-T. Yang, and P.-J. Gao, “Passage-restricted differentiation potential of mesenchymal stem cells into cardiomyocyte-like cells,” Biochemical and Biophysical Research Communications, vol. 336, no. 3, pp. 784–792, 2005.